Skip to main content

Heron Therapeutics, Inc 10-K for FY2025

Heron Therapeutics, Inc. (HRTX)

10-K 2026-02-26 For: 2025-12-31
View Original
Added on April 09, 2026

About this 10-K

Heron Therapeutics, Inc filed this 10-K on February 26, 2026, covering the fiscal year ended December 31, 2025 (FY2025).

Headline figures

Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$154.9M
up 7.4% from $144.29M a year earlier
Net loss
$20.2M
compared with a net loss of $13.58M a year earlier
Diluted EPS
-$0.12
compared with -$0.09 a year earlier